87 related articles for article (PubMed ID: 8815635)
1. [Flow-cytometric study of aneuploidy and proliferative activity of endometrial cancer cells as indicators of tumor aggressiveness].
Bychkova NV; Meshkova IE; Pozharisskiĭ KM
Vopr Onkol; 1996; 42(2):57-62. PubMed ID: 8815635
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell cycle in patients with stage I endometrial carcinoma.
Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
[TBL] [Abstract][Full Text] [Related]
3. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
5. [Aneuploidy and proliferative activity in breast cancer (flow-cytometric investigation)].
Bychkova NV; Pozharisskiĭ KM
Vopr Onkol; 1997; 43(2):171-5. PubMed ID: 9214117
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
7. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of flow cytometrical DNA measurements in stage I-II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion, and degree of differentiation.
Lindahl B; Alm P; Fernö M; Killander D; Långström E; Norgren A; Trope C
Anticancer Res; 1987; 7(4B):791-7. PubMed ID: 3674764
[TBL] [Abstract][Full Text] [Related]
10. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the ploidy and cell proliferation of malignant epithelial neoplasms of various origin (flow cytometric assay)].
Bychkova NV; Meshkova IE; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(1):54-9. PubMed ID: 9578732
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract][Full Text] [Related]
13. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
[TBL] [Abstract][Full Text] [Related]
14. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
15. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy.
Genest DR; Sheets E; Lage JM
Am J Clin Pathol; 1994 Sep; 102(3):341-8. PubMed ID: 8085558
[TBL] [Abstract][Full Text] [Related]
16. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
17. 11q23-24 loss is associated with chromosomal instability in endometrial cancer.
Kawasaki K; Suehiro Y; Umayahara K; Morioka H; Ito T; Saito T; Tsukamoto N; Sugino N; Kato H; Sasaki K
Int J Mol Med; 2003 Nov; 12(5):727-31. PubMed ID: 14533001
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
19. DNA index by image analysis in advanced endometrial carcinoma.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
J Surg Oncol; 1996 Oct; 63(2):91-4. PubMed ID: 8888800
[TBL] [Abstract][Full Text] [Related]
20. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
